FLYYQ Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Spirit Aviation Holdings, Inc. Class Action Lawsuit

Robbins LLPreminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Spirit Aviation Holdings, Inc. (NASDAQ: FLYYQ) securities between May 28, 2025 and August 29, 2025. Spirit is the parent company of Spirit Airlines, LLC, an ultra-low-cost American airline that provides passenger air transportation services for […]

FLYYQ Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Spirit Aviation Holdings, Inc. Class Action Lawsuit

Robbins LLPreminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Spirit Aviation Holdings, Inc. (NASDAQ: FLYYQ) securities between May 28, 2025 and August 29, 2025. Spirit is the parent company of Spirit Airlines, LLC, an ultra-low-cost American airline that provides passenger air transportation services for

Robbins LLP Reminds Cytokinetics, Inc. Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Against CYTK

RobbinsLLPreminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating

MUSE Maps Expansion into Asia to Pioneer a New Era of Investment-Grade Real Assets

— After launching successfully in Q1 2025, MUSE plans its strategic expansion into Asia — The world's first investment-grade luxury asset platform opens a limited window for Asia's most visionary investors to co-create a new financial order MUSE (MUSE Technology Pty Ltd), an Australian-headquartered technology firm, today announced the expansion of its business into Asia.

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

(NASDAQ:QLGN), Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and supporting the Company's next phase of strategic growth. Executive Appointments Effective October 2, 2025, Jerry (Jiawei) Wang was appointed

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit – UNCY

(NASDAQ:UNCY), NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”), of the important October 14, 2025 lead plaintiff deadline. SO WHAT: If

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition GlobeNewswire October 06, 2025 Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and supporting the Company's

Court Dismisses Key Fraud Allegations in LuxUrban Securities Case, Leaving Narrow Disclosure Dispute According to New Stanford Legal Report

Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) — U.S. District Judge Paul Engelmayer ruled that claims related to LuxUrban's Q1 2024 financial statements failed to meet the standard for pleading fraud. As a result, the core financial fraud allegations were dismissed. The remaining claims are limited to whether certain hotel properties were accurately described

Scroll to Top